enfortumab vedotin appears well-tolerated and active in advanced bladder cancers
Published 4 years ago • 193 plays • Length 0:50Download video MP4
Download video MP3
Similar videos
-
6:09
enfortumab vedotin for previously-treated advanced urothelial carcinoma
-
2:52
enfortumab vedotin in urothelial cancer
-
1:27
dr. sonpavde on enfortumab vedotin data in bladder cancer
-
1:09
enfortumab vedotin: targeting bladder cancer
-
3:25
enfortumab vedotin with pembrolizumab for bladder cancer
-
4:16
unite: enfortumab vedotin in advanced urothelial cancer
-
6:01
enfortumab vedotin plus pembrolizumab improves overall survival for advanced bladder cancer
-
1:58
enfortumab vedotin for the treatment of advanced urothelial cancer
-
2:58
ev-201: enfortumab vedotin for cisplatin-ineligible bladder cancer
-
2:39
enfortumab vedotin approved by fda for patients with refractory urothelial carcinoma
-
3:14
the role of enfortumab vedotin in earlier lines and stages of urothelial cancer | arjun balar
-
13:47
ev-103: enfortumab vedotin and pembrolizumab in urothelial carcinoma
-
3:07
enfortumab vedotin in urothelial cancer
-
2:03
dr. petrylak on enfortumab vedotin in locally advanced or metastatic urothelial carcinoma
-
20:21
targeted therapy for the treatment of advanced metastatic urothelial cancer youtube
-
22:27
2021 west oncology | genitourinary cancers | latest updates on advanced bladder cancer
-
3:24
enfortumab vedotin as treatment for urothelial carcinomas
-
2:20
ev-201: enfortumab vedotin for bladder cancer
-
27:17
advanced bladder cancer: chemotherapy & immunotherapy